NMPA Approval

Human Albumin

Approval Number

国药准字SJ20190037

Registration Date

September 20, 2024

Previous Approval Numbers

S20190037

Drug Information

Generic Name

人血白蛋白

Trade Name

Plasbumin-25

Dosage Form

注射剂

Strength

12.5g/瓶（25%,50ml)

Drug Type

生物制品

Registration Date

September 20, 2024

Expiry Date

September 19, 2029

Company Name基立福

Company Address

79 T.W. Alexander Drive 4101 Research Commons，Research Triangle Park，NC 27709, USA

Company Name基立福

Company Address

8368 US 70 Business Hwy West, Clayton, NC 27520, USA

Empowering clinical research with data-driven insights and AI-powered tools.

人血白蛋白 - NMPA 批准文号 | MedPath